The urgency for new and improved cattle vaccines and diagnostic reagents for Bovine tuberculosis (TB) has made their development a research priority in Great Britain (GB). Significant progress has been made to develop specific antigens that allow the differentiation of BCG vaccinated and M. bovis infected cattle (DIVA test). This has been greatly facilitated by the completion of the genome sequences of M. tuberculosis, M. bovis and BCG Pasteur and the subsequent application of comparative genome and transcriptome analysis to define DIVA antigens that complemented the prototype DIVA antigens ESAT-6 and CFP-10 by increasing their test sensitivity. Finally, we present an update of our current approaches in this area.
Keywords: DIVA, BCG, Mycobacterium tuberculosis, Mycobacterium bovis, differential diagnosis, antigen reagentsPage 3 of 26 A c c e p t e d M a n u s c r i p t 3
Development of cattle TB vaccinesOver the last two decades the (tuberculin) test and slaughter strategy failed to prevent a dramatic rise in the incidence of TB in cattle in England and Wales (http://www.defra.gov.uk/animalh/tb/stats/county.htm). The urgency for new and improved cattle vaccines and diagnostic reagents has been acknowledged by the United Kingdom government.(http://www.defra.gov.uk/animalh/tb/vaccination/index.htm).However, the short-term development of improved cattle TB vaccines faces two major challenges: The identification of vaccine strategies that enhance the efficacy of M. bovis bacille Calmette Guérin (BCG), and the development of a diagnostic test that can be used alongside vaccination to differentiate vaccinated and infected cattle (DIVA test).The significant progress in developing TB vaccines for cattle has been reviewed in a number of recent articles Buddle et al., 2006; Hogarth et al., 2006; Hope and Vordermeier, 2005; Vordermeier et al., 2006a; Vordermeier and Hewinson, 2006). Briefly, results in cattle have shown that the most effective vaccination strategy against bovine TB is based on priming the immune system with BCG followed by boosting with subunit vaccines containing protective antigens that are present in BCG (heterologous prime-boost strategy), DNA (Skinner et al., 2003;, protein , or viral subunit vaccines (Vordermeier et al., 2006b; Vordermeier et al., 2004;Vordermeier et al., 2009). Nevertheless, all these strategies resulted in at least a proportion of animals becoming tuberculin-test positive (both in tuberculin skin and IFN-! tests). Thus, the development of
Differential diagnosis of infected from vaccinated individuals (DIVA).Bovine tuberculosis in cattle is viewed as a spectral disease with cellmediated immune responses developing early post-infection and serum responses becoming patent at later and advanced stages of disease Pollock et al., 2001;Ritacco et al., 1991). Therefore, diagnostic assays like tuberculin skin testing or in vitro cytokine detection assays as the generally suffered from poor sensitivity. However, it should be noted that recent advances in this technology using b...